Department of Cardiothoracic Surgery University of Pittsburgh Pittsburgh, PA.
UPMC Heart and Vascular Institute, University of Pittsburgh Medical Center Pittsburgh PA.
J Am Heart Assoc. 2023 Sep 19;12(18):e030629. doi: 10.1161/JAHA.123.030629. Epub 2023 Sep 8.
Background An aspect not so clear in the scenario of aortic surgery is how patients fare after composite aortic valve graft replacement (CAVGR) depending on the type of valve (bioprosthetic versus mechanical). We performed a study to evaluate the long-term outcomes of both strategies comparatively. Methods and Results Pooled meta-analysis of Kaplan-Meier-derived time-to-event data from studies with follow-up for overall survival (all-cause death), event-free survival (composite end point of cardiac death, valve-related complications, stroke, bleeding, embolic events, and/or endocarditis), and freedom from reintervention. Twenty-three studies met our eligibility criteria, including 11 428 patients (3786 patients with mechanical valves and 7642 patients with bioprosthetic valve). The overall population was mostly composed of men (mean age, 45.5-75.6 years). In comparison with patients who underwent CAVGR with bioprosthetic valves, patients undergoing CAVGR with mechanical valves presented no statistically significant difference in the risk of all-cause death in the first 30 days after the procedure (hazard ratio [HR], 1.24 [95% CI, 0.95-1.60]; =0.109), but they had a significantly lower risk of all-cause mortality after the 30-day time point (HR, 0.89 [95% CI, 0.81-0.99]; =0.039) and lower risk of reintervention (HR, 0.33 [95% CI, 0.24-0.45]; <0.001). Despite its increased risk for the composite end point in the first 6 years of follow-up (HR, 1.41 [95% CI, 1.09-1.82]; =0.009), CAVGR with mechanical valves is associated with a lower risk for the composite end point after the 6-year time point (HR, 0.46 [95% CI, 0.31-0.67]; <0.001). Conclusions CAVGR with mechanical valves is associated with better long-term outcomes in comparison with CAVGR with bioprosthetic valves.
在主动脉手术的情况下,有一个方面尚不清楚,即根据瓣膜类型(生物假体与机械),患者在复合主动脉瓣移植置换(CAVGR)后的预后如何。我们进行了一项研究,以比较这两种策略的长期结果。
对具有总体生存(全因死亡)、无事件生存(心脏死亡、瓣膜相关并发症、卒中等复合终点)和无再次介入随访的研究进行了 Kaplan-Meier 衍生时间事件数据的汇总荟萃分析。23 项研究符合我们的纳入标准,包括 11428 名患者(3786 名患者使用机械瓣膜,7642 名患者使用生物假体瓣膜)。总体人群主要由男性组成(平均年龄 45.5-75.6 岁)。与接受生物假体瓣膜 CAVGR 的患者相比,接受机械瓣膜 CAVGR 的患者在手术后 30 天内全因死亡的风险无统计学显著差异(风险比 [HR],1.24 [95%可信区间,0.95-1.60];=0.109),但在 30 天后全因死亡率的风险显著降低(HR,0.89 [95%可信区间,0.81-0.99];=0.039),再次介入的风险也降低(HR,0.33 [95%可信区间,0.24-0.45];<0.001)。尽管机械瓣膜 CAVGR 在随访的前 6 年复合终点的风险增加(HR,1.41 [95%可信区间,1.09-1.82];=0.009),但在 6 年时间点后,机械瓣膜 CAVGR 与复合终点的风险降低(HR,0.46 [95%可信区间,0.31-0.67];<0.001)。
与生物假体瓣膜 CAVGR 相比,机械瓣膜 CAVGR 与更好的长期结果相关。